Biogen Inc

Biotechnology

BIIB

$ 227 (0.6)%

Share price

$ 33 bn

Market Cap

$ 39 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.07x the weighted average for S&P 500

FY2022

Primary Climate Goal

Proj. YOY change in GHG emissions (Scope 1 + 2)

Weaker than the -8.2% weighted average for S&P 500

FY2023

Biogen Inc aims to reduce Scope 1 + 2 by 55% by 2032 from a base year 2019

1.5°C

GHG emissions and Carbon intensity

Biogen Inc reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2022 at 97 Kt (-0.81 /-0.8% y-o-y). At the same time, carbon intensity was up at 9.5 t (+0.6/+6.7% y-o-y).

Biogen Inc's Scope 3 emissions was up at 435 Kt (+28/+6.9% y-o-y). This is broadly in line with the growth trend (CAGR +7.6% since 4Q'20).

The company is committed to reducing Scope 1 + 2 by 55% by 2032 from a base year 2019, which translates into the estimated reduction of -4.9 Kt per annum over the period of FY2023 - FY2032. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Date	Total CO2e emissions (location-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2022Q4	97	65	32	435	10,173	9.5
2021Q4	97	63	34	406	10,982	8.9
2020Q4	95	58	37	349	13,445	7
2019Q4	105	67	38	425	14,378	7.3
2018Q4	106	68	37	436	13,453	7.9
2017Q4	103	62	41	482	12,274	8.4
2016Q4	108	62	46	255	11,449	9.4
2015Q4	98	60	38	262	10,764	9.1

Biogen Inc

Carbon footprint

Primary Climate Goal

Biogen Inc aims to reduce Scope 1 + 2 by 55% by 2032 from a base year 2019

GHG emissions and Carbon intensity

Biogen Inc's carbon footprint

Company environmental metrics